Unveiling CKS2: A Key Player in Aggressive B‐Cell Lymphoma Progression and a Target for Synergistic Therapy
ABSTRACT Background The objective of this study was to investigate the expression levels and biological significance of CKS2 in Burkitt cell lymphoma (BL) and diffuse large B‐cell lymphoma (DLBCL). Additionally, the potential synergistic anti‐tumor effects of CKS2 knockdown in combination with etopo...
Saved in:
| Main Authors: | Fenling Zhou, Lu Chen, Zhen Liu, Yuli Cao, Cuilan Deng, Gexiu Liu, Chengcheng Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-11-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.70435 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Very late relapse of Burkitt's lymphoma in an EBV-negative patient after 20 years of complete remission
by: Kmar Mrad, et al.
Published: (2024-01-01) -
DNMT1 blocks SOX21-repressed CKS2 transcription to promote gastric cancer progression
by: Jie Wei, et al.
Published: (2025-07-01) -
The single-cell immune landscape of HIV-associated aggressive B-cell lymphoma
by: Xiaomei Zhang, et al.
Published: (2025-04-01) -
Primary Lymphoma of the Gynecologic Tract: A Comprehensive Pathologic Analysis of 15 Cases
by: Haneen Al-Maghrabi, et al.
Published: (2025-04-01) -
Atypical presentation of oral Burkitt lymphoma in an adult: a case report
by: Rajae El Gaouzi, et al.
Published: (2024-12-01)